Raymond surges 7% as realty subsidiary set to debut on bourses
Synopsis Raymond shares surged 7% as Raymond Realty Ltd (RRL) debuts on stock exchanges today, following a demerger granting Raymond shareholders one RRL share per Raymond share. RRL, now independent, offers direct real estate exposure. SBI Securities projects a listing price between Rs 897 and Rs 1,430, based on FY26 EV/EBITDA multiples. Shares of Raymond surged 7% as its real estate subsidiary, Raymond Realty Ltd (RRL), is set to debut on the stock exchanges today, July 1, marking a major milestone in the group's restructuring efforts. The listing follows a recent demerger, with Raymond shareholders receiving one RRL share for every Raymond share held.
ADVERTISEMENT RRL, now operating as an independent, pure-play real estate entity, offers investors direct exposure to the group's real estate business for the first time. According to SBI Securities, the stock is likely to list between Rs 897 and Rs 1,430, based on projected FY26 EV/EBITDA multiples of 11–15x and EBITDA growth forecasts of 0–20% over FY25.
Raymond's share price is currently at Rs 756.10, reflecting a 6.59% increase from its previous close of Rs 624.35. The company's market capitalization now stands at Rs 4,722.74 crore. Over the past six months, the stock has declined by 55.37%.
During the last 52 weeks, Raymond's share price has touched a high of Rs 3,496.00 and a low of Rs 523.10.The stock has a Price-to-Earnings (P/E) ratio of 0.62 and a Price-to-Book (P/B) ratio of 1.14.The 14-day Relative Strength Index (RSI) is at 53.7, with RSI levels below 30 considered oversold and above 70 considered overbought.
(You can now subscribe to our ETMarkets WhatsApp channel)
Nikita Papers IPO opens on May 27, price band set at Rs 95-104 per share
Nikita Papers IPO opens on May 27, price band set at Rs 95-104 per share Why gold prices could surpass $4,000: JP Morgan's bullish outlook explained
Why gold prices could surpass $4,000: JP Morgan's bullish outlook explained Cyient shares fall over 9% after Q4 profit declines, core business underperforms
Cyient shares fall over 9% after Q4 profit declines, core business underperforms L&T Technology Services shares slide 7% after Q4 profit dips
L&T Technology Services shares slide 7% after Q4 profit dips Trump-Powell standoff puts U.S. Rate policy in crosshairs: Who will blink first?
Trump-Powell standoff puts U.S. Rate policy in crosshairs: Who will blink first? SEBI warns of securities market frauds via YouTube, Facebook, X and more
SEBI warns of securities market frauds via YouTube, Facebook, X and more API Trading for All: Pi42 CTO Satish Mishra on How Pi42 is Empowering Retail Traders
API Trading for All: Pi42 CTO Satish Mishra on How Pi42 is Empowering Retail Traders Security, transparency, and innovation: What sets Pi42 apart in crypto trading
Security, transparency, and innovation: What sets Pi42 apart in crypto trading Bitcoin, Ethereum, or Altcoins? How investors are structuring their crypto portfolios, Avinash Shekhar explains
Bitcoin, Ethereum, or Altcoins? How investors are structuring their crypto portfolios, Avinash Shekhar explains The rise of Crypto Futures in India: Leverage, tax efficiency, and market maturity, Avinash Shekhar of Pi42 explains
NEXT STORY
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
25 minutes ago
- Time of India
ET Market Watch: Sensex gains 90 pts, Nifty holds 25,500 ahead of US tariff deadline
Transcript Hi, you're listening to ET Markets Radio, I am your host, Neha V Mahajan. Welcome to a fresh episode of ET Market Watch -- where we bring you the latest news from the world of stock markets every single day. Let's get to it: Sensex gained 90 points. Nifty held above 25,500. Investors stayed cautious as US trade talks loomed. On Tuesday, Indian markets edged higher, tracking gains in Asia. Sensex closed at 83,697, up 0.11% Nifty at 25,541, up 0.1% Gains were capped by weak financials and trade deal jitters ahead of Trump's July 9 tariff deadline. Sector Moves & Stock Highlights Reliance rose 1.8% after Nuvama raised its target to ₹1,801, citing new energy growth. Bharat Electronics, Asian Paints, UltraTech Cement, and Kotak Bank gained up to 2.5%. Financials eased 0.2% for a second day, but PSU banks outperformed, Nifty PSU Bank up 0.7%. Key Movers Apollo Hospitals surged 3.5% after announcing a spin-off of its digital and pharmacy biz. Sigachi Industries plunged another 5.6%, extending its two-day loss to over 17% after the Telangana plant tragedy. Technical Views Kotak Securities said markets showed lacklustre activity, forming a narrow-range candlestick. Key resistance: 25,600 on Nifty, 83,900 on Sensex Key support: 25,470 / 83,500 HDFC Securities sees higher highs on charts, with a breakout above 25,700 likely taking Nifty to 26,000+. Global Cues & Rupee Asian stocks rose as US trade talks and a $3.3 trillion spending bill hung in the balance. Rupee firmed up 0.3% to 85.52 against the dollar. Crude held steady, Brent at $66.79, WTI at $65.15. Markets stayed range-bound, but positioning hints at a breakout, with trade talks, earnings, and global data in focus.
Indian Express
32 minutes ago
- Indian Express
Trump says he won't extend July 9 trade deadline, expresses doubt on Japan deal
President Donald Trump said on Tuesday he was not thinking of extending the July 9 deadline for countries to negotiate trade deals with the US, and continued to express doubt that an agreement could be reached with Japan. 'We've dealt with Japan. I'm not sure we're going to make a deal. I doubt it,' Trump told reporters aboard Air Force One as he returned to Washington from a trip to Florida. Trump suggested he could impose a tariff of '30% or 35% or whatever the number is that we determine' on imports from Japan – well above the 24% tariff rate he announced on April 2 and then later paused.
Time of India
34 minutes ago
- Time of India
Ghaziabad hospital told to pay retired railway employee s 17k for claim process delay
Ghaziabad: District Consumer Disputes Redressal Commission (DCDRC) has directed the Northern Railways chief medical superintendent (CMS) to pay over Rs 17,000 to a retired railway employee — as reimbursement and compensation for claim delay. While payment of Rs 12,398 has been ordered as treatment reimbursement for cataract surgery, that of Rs 5,000 has been directed as the compensation for delaying the payment of the claim. The commission also directed the payment to be made within 45 days of the order, failing which interest calculated at 6% would have to be paid. You Can Also Check: Noida AQI | Weather in Noida | Bank Holidays in Noida | Public Holidays in Noida Passing the order on June 23, the commission, presided over by Praveen Kumar Jain, said railway authorities should have taken necessary steps to initiate payment instead of rejecting the claim on the grounds of incomplete papers "when the claimant is a retired employee of the railways". Devilal Singh, who superannuated from the post of chief medical superintendent (CMS) in 2012, had filed an application before the DCDRC for direction to CMS, Delhi divisional office and assistant chief medical superintendent (ACMS) of Railway Hospital Ghaziabad. The complainant said during retirement, he was provided with a medical card covering him and his family members. He told the commission, "When I felt some problem with my right eye, I consulted the doctors at JP Hospital, Noida, and underwent a surgery on April 10, 2019, for which I paid Rs 35,890. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Giao dịch CFD với công nghệ và tốc độ tốt hơn IC Markets Đăng ký Undo Once again, I had some issues with my right eye and was advised by doctors at JP Hospital to undergo a cataract surgery, which was conducted on Oct 1, 2019. This time, I paid Rs 30,500 towards the bills raised by the hospital. When I applied for reimbursement of the treatment cost with ACMS (Railway Hospital Ghaziabad) with all relevant documents, it was rejected, which was not just a deficiency in services but also illegal. " The complainant later filed an RTI application and was informed by the railways that his first claim of Rs 35,890 was settled by the railway department by paying Rs 1,786, as was admissible under the policy of Central Govt Health Service (CGHS). The complainant contended that since he was an employee of the railway, his claims could not be dealt with under the CGHS policy and were governed by the railway board. The counsel for the opponents said that railway authorities follow the railway board policy of 2005, effective since Jan 2007, under which beneficiaries can obtain treatment at hospitals recognised by the railways. "The beneficiaries are free to obtain treatment at any hospital of their choice, but in that case, reimbursement is done according to CGHS rates as applicable," the counsel said. He told the commission the second claim was rejected for inadequacy of documents. Get the latest lifestyle updates on Times of India, along with Doctor's Day 2025 , messages and quotes!
